This Viewpoint advocates for more careful consideration of families and children in policymaking surrounding naloxone coprescribing or accessibility. Share: Previous Post Effects on Body Mass Index After the Philadelphia Beverage Tax Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Vitamin D Supplementation and Development Among School-aged Children in an Area With Vitamin D Deficiency Clinical Practice Guidelines JAMA Pediatrics Clinical Practice Guidelines Advancing Evidence-Based Peripheral Intravenous Catheter Securement Clinical Practice Guidelines Prevalence of Depressive Disorders in Children From 2004 to 2019 Clinical Practice Guidelines Newborn Screening—What Parents Need to Know About Their Infant’s First Tests Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.